Polydex Pharma Balance Sheet - Quarterly (OTCMKTS:POLXF)

Add to My Stocks
$0.98 $0 (0%) POLXF stock closing price Sep 18, 2018 (Closing)

A balance sheet is one of the three key financial statements released by a publicly listed company like Polydex Pharma, and helps in stock analysis. All three financial statements should be used to measure the financial performance of the company, and should form a part of the Polydex Pharma stock analysis. Good quarterly results indicate a company's strong financial performance. Its important to check all financial statements including the balance sheet. The balance sheet shows total liabilities of $1.56M and shareholders equity of $5.76M. Polydex Pharma revenue and Polydex Pharma operating cash flow are important in understanding the financial capacity of the company.

View and download Polydex Pharma quarterly results to get the balance sheet details for the latest 40 quarters data.
show more
Quarterly
Annual
View Previous Quarters
View Next Quarters
Fiscal year is Feb - Jan2018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q4
Cash---1.07M-1.4M---
Marketable Securities---------
Receivables1.54M1.27M--1.1M-1.12M1.03M-
Inventory1.03M1.05M1.17M1.18M1.15M1.14M-1.11M-
Raw Materials---------
Work In Progress---------
Finished Goods---------
Notes Receivable---------
Other Current Assets---------
Total Current Assets
3.93M3.55M3.53M3.81M3.6M3.7M3.4M3.32M2.83M
Property Plant & Equipment12.97M---4.28M---10.78M
Accumulated Depreciation9.6M---1.22M---8.01M
Net Property Plant & Equipment
3.36M3.33M3.12M2.88M3.05M2.98M3.03M3.06M2.76M
Investment & Advances---------
Other Non-Current Assets---------
Deferred Charges---------
Intangibles---------
Deposits & Other Assets---------
Total Assets
7.32M6.9M6.68M6.71M6.7M6.75M6.55M6.62M5.81M
Notes Payable---------
Accounts Payable---------
Current Portion Long-Term Debt---------
Current Portion Capital Leases---------
Accrued Expenses---------
Income Taxes Payable---------
Other Current Liabilities---------
Total Current Liabilities
---1.34M1.14M1.43M1.28M1.37M1.21M
Mortgages---------
Deferred Taxes/Income---------
Convertible Debt---------
Long-Term Debt---------
Non-Current Capital Leases---------
Other Long-Term Liabilities---------
Total Liabilities
1.56M1.38M1.35M1.83M1.66M1.97M1.85M1.98M1.83M
Minority Interest---------
Preferred Stock---------
Common Stock Net---------
Capital Surplus23.8M23.8M23.8M23.8M23.8M23.79M23.79M23.79M23.79M
Retained Earnings-18.77M-18.85M-19.09M-19.07M-19.22M-19.28M-19.53M-19.81M-19.88M
Treasury Stock---------
Other Liabilities---------
Shareholders Equity5.76M5.52M5.33M4.88M5.04M4.77M4.69M4.64M3.98M
Total Liabilities & Shareholders Equity7.32M6.9M6.68M6.71M6.7M6.75M6.55M6.62M5.81M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Apart from balance sheet items, an investor would do well to keep track of the Polydex Pharma stock price by looking at Polydex Pharma historical stock prices. One can compare PE with industry average by looking at the Polydex Pharma PE ratio chart. The common balance sheet items are:

  • Assets: Anything that the Polydex Pharma company owns and is a part of its books. Assets can be of three types: fixed, current and other assets which includes intangibles, advances. Internet companies typically don't have a lot of assets as there is not much investment in say machinery, equipment etc. Polydex Pharma had total assets of $7.32M.
  • Liabilities: The total liabilities of Polydex Pharma for the quarter 2018 Q4 total to $1.56M. Liabilities for a company like Polydex Pharma include bank loans, services which have been availed for which a settlement in the form of cash/ asset transfer needs to be done in future etc. A firm takes on such obligations to grow its business which in turn will generate future economic benefits for its business.

Polydex Pharma Balance Sheet - Key Ratios

Current ratio
0
Debt to equity ratio
0
Asset turnover ratio
0
Receivables turnover
0